Does Delaying Drug Treatment of Patients With Ocular Hypertension Increase the Risk of Glaucoma?
March 12, 2010
Submit Comments
As reported on MedPage Today, researchers recently found that providing earlier drug treatment to patients with ocular hypertension decreased the risk of glaucoma.
Specifically, among patients at high risk for glaucoma, 28% of those started on topical medication for ocular hypertension developed primary open-angle glaucoma, compared with 40% of those who went untreated for eight years before beginning medication.
Read more about the study on MedPage Today.
You might also enjoy...
- Patients with Open-Angle Glaucoma Have Increased Risk of Stroke
- Do Travoprost Eye Drops Produce Lower Diurnal IOP Than Tafluprost Eye Drops?
- New Lumigan Eye Drop Formulation for Glaucoma From Allergan Approved by FDA
- Aton Pharma Acquires Marketing Rights to Preservative-Free Timolol Product Line from Merck
- Injections of Cortisol Derivative Reduced Intraocular Pressure in Glaucoma Patients
Comments
Jump down to form below to submit your own comments
